
Ticarsh 90mg Tablet
Marketer
Kasdap Healthcare Pvt Ltd
Salt Composition
Ticagrelor (90mg)
Overview Ticarsh 90mg Tablet
CardioGuard 90mg tablets are antiplatelet agents, also known as blood thinners. They inhibit the creation of dangerous blood clots within blood vessels, thus lowering the risk of stroke or heart attack in patients with cardiac conditions. CardioGuard 90mg is also indicated for individuals recovering from a myocardial infarction or experiencing unstable angina, particularly those who have received coronary stenting. This medication helps prevent future cardiac events, including recurrent heart attacks, strokes, and stent thrombosis. Concurrent use with aspirin, another antiplatelet drug, is typically prescribed. CardioGuard 90mg can be administered with or without food, consistently at the same time daily. Continuous use is crucial, even during periods of well-being, as discontinuation increases the risk of cardiac events. The most prevalent side effect is increased bleeding tendency; injuries may bleed more profusely and for longer durations. While usually mild and self-resolving, persistent bleeding should be reported. Some patients experience mild dyspnea, typically subsiding with ongoing treatment; worsening or persistent shortness of breath requires medical attention. CardioGuard 90mg is contraindicated in individuals with active internal bleeding (e.g., ulcers, intracranial hemorrhage) and those with hepatic impairment. Pre-existing conditions should be disclosed to your physician before initiating treatment.
Uses of Ticarsh 90mg Tablet
Reducing the risk of cardiac arrest and cerebrovascular accidents
Major Benefits of Ticarsh 90mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Ticarsh 90mg Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Ticarsh 90mg Tablet:
- Bleeding
- Breathlessness
How to use Ticarsh 90mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the 90mg Ticarsh Tablet whole; avoid chewing, crushing, or fracturing it. Consumption with or without food is acceptable, although consistent timing is recommended.
How Ticarsh 90mg Tablet works:
Ticarsh 90mg tablets inhibit platelet aggregation, a process crucial in blood clot formation. This antiplatelet action reduces the risk of cardiovascular events such as heart attack and stroke.
SAFETY ADVICE
AlcoholCAUTION
Use of alcohol with Ticarsh 90mg Tablets should be approached with care. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Ticarsh 90mg Tablet during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescribing. Consult your doctor for advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Ticarsh 90mg Tablet with breastfeeding is lacking. Seek medical advice from your physician.
DrivingSAFE
Driving ability is typically unaffected by Ticarsh 90mg Tablets.
KidneySAFE IF PRESCRIBED
Ticarsh 90mg tablets are considered safe for individuals with kidney impairment; no dosage modification is advised. Data regarding Ticarsh 90mg tablet use in patients undergoing renal dialysis is currently limited.
LiverCAUTION
Patients with liver impairment should use Ticarsh 90mg Tablets cautiously, potentially requiring dosage modification. Severe hepatic dysfunction contraindicates Ticarsh 90mg Tablet use; consult a physician before taking this medication.
What if you forget to take Ticarsh 90mg Tablet :
Should you forget a Ticarsh 90mg Tablet dose, take it immediately. If your next dose is nearly due, however, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Ticarsh 90mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Triazolopyrimidine derivatives |
| Developing Habits | No. |
| Type of Therapy | KINSHIP |
| Actions | ADP receptor antagonists (P2Y12 inhibitors) |
